Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• N-(4-hydroxyphenyl)retinamide (4HPR) previously demonstrated efficacy in inhibiting retinoblastoma tumor growth and inducing cell death in Y79 retinoblastoma cells.
• Understanding the precise mechanisms of 4HPR-induced cell death is crucial for its therapeutic application.

Purpose of the Study:

• To investigate the cell death pathways activated by 4HPR in Y79 retinoblastoma cells, focusing on mitochondrial and lysosomal integrity.
• To determine the role of caspases, reactive oxygen species, and lysosomal enzymes in 4HPR-mediated cytotoxicity.

Main Methods:

• Y79 retinoblastoma cells were treated with 4HPR, and various cell death parameters were assayed, including mitochondrial damage, caspase activation, DNA fragmentation, and lysosomal membrane permeabilization.
• Pharmacologic inhibitors of caspases (BOC-D-fmk, Z-DEVD-fmk), cathepsin D inhibitor (Pepstatin A), and an antioxidant (N-acetylcysteine) were used to elucidate the cell death pathway.
• Cell viability, lactate dehydrogenase release, mitochondrial transmembrane potential (Deltapsi(m)), and ATP levels were measured.
• The study also examined other cancer cell lines, including PC3 prostate adenocarcinoma and Kaposi sarcoma KS-Imm cells.

Main Results:

• 4HPR induced cytochrome c release, caspase-3 activation, and DNA fragmentation, but caspase inhibition did not prevent cell death.
• 4HPR caused lysosomal membrane permeabilization and cathepsin D release into the cytosol, which was partially rescued by Pepstatin A.
• Lysosomal destabilization was dependent on reactive oxygen species elevation and preceded mitochondrial dysfunction.
• Insulin-like growth factor I-mediated AKT activation was impaired, and its protective effects against ATP and Deltapsi(m) loss were blocked by 4HPR.
• Lysosomal destabilization and mitochondrial dysfunction were observed in other cancer cell lines (PC3, KS-Imm).

Conclusions:

• 4HPR induces cancer cell death primarily through a lysosome-mediated pathway involving lysosomal membrane permeabilization and cathepsin D release, rather than solely through caspase activation.
• Reactive oxygen species play a critical role in initiating lysosomal destabilization, which precedes mitochondrial dysfunction.
• The findings suggest that targeting lysosomal integrity is a viable strategy for cancer therapy and chemoprevention, potentially in combination with other agents.